KBC Group’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-451,912
Closed -$917K 1355
2016
Q1
$917K Buy
451,912
+137,209
+44% +$245K 0.02% 666
2015
Q4
$780K Buy
314,703
+32,098
+11% +$95.2K 0.01% 683
2015
Q3
$735K Buy
282,605
+57,239
+25% +$149K 0.01% 671
2015
Q2
$708K Buy
225,366
+45,707
+25% +$157K 0.01% 804
2015
Q1
$514K Buy
179,659
+6,139
+4% +$15.7K 0.01% 894
2014
Q4
$447K Buy
173,520
+94,516
+120% +$414K 0.01% 1004
2014
Q3
$589K Sell
79,004
-19,144
-20% -$179K 0.02% 687
2014
Q2
$1.16M Buy
98,148
+31,383
+47% +$335K 0.01% 721
2014
Q1
$775K Buy
66,765
+5,297
+9% +$62.3K 0.01% 716
2013
Q4
$669K Sell
61,468
-2,673
-4% -$26.3K 0.01% 778
2013
Q3
$692K Buy
64,141
+17,669
+38% +$201K 0.01% 753
2013
Q2
$545K Buy
+46,472
New +$464K 0.01% 797

KBC Group's SZYM Position: Q2 2016 in Review

KBC Group sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 451,912 shares — an estimated $917K sold.

KBC Group first reported a position in SZYM in Q2 2013 and held it in 12 quarters. The position peaked at $1.16M in Q2 2014. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

  • KBC Group reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • KBC Group sold 451,912 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $917K.
  • KBC Group first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 12 quarters.
  • KBC Group's SOLAZYME INC COM STK (DE) position peaked at $1.16M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on KBC Group's 13F filing for Q2 2016, filed 3 Aug 2016.